In five patients with sclerodermatous c-GVHD, Shimura et al. found a reduction in circulating CD34+/CD133+ putative endothelial precursors when compared to controls and c-GVHD patients without fibrosis of the skin. This evidence concerns the gene PROM1 and graft versus host disease.